The Valley Desk

NCT07047716 · Interventional trial

Study of Lenacapavir as a Once-Yearly Injection for HIV Pre-exposure Prophylaxis (PrEP)

Overall registry status Active not recruiting

Phase 3

Conditions HIV Pre-exposure Prophylaxis

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov